Kapbro Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 08-07-2024
- Paid Up Capital ₹ 3.02 M
as on 08-07-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.08 Cr
as on 08-07-2024
- Satisfied Charges ₹ 5.75 Cr
as on 08-07-2024
About Kapbro Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.02 M.
The company currently has active open charges totaling ₹5.08 Cr. The company has closed loans amounting to ₹5.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prem Kapoor, Manish Kapoor, Renu Kapoor, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24233DL2005PTC134804
- Company No.
134804
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Kapbro Pharma Private Limited offer?
Kapbro Pharma Private Limited offers a wide range of products and services, including FRP Lining, PU & Powder Coatings, Powder Coatings, Anti Infective Drugs & Medicines, Antiviral Drugs, Respiratory System Drugs, Asthma Inhaler, Common Disease Medicines, Pharmaceutical Tablets, TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Kapbro Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prem Kapoor  | Director | 07-Apr-2005 | Current |
| Manish Kapoor | Director | 16-Dec-2022 | Current |
| Renu Kapoor | Director | 07-Apr-2005 | Current |
| Saroj Kapoor | Director | 07-Apr-2005 | Current |
| Arun Kapoor | Director | 07-Apr-2005 | Current |
Financial Performance and Corporate Structure Insights of Kapbro Pharma.
Kapbro Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kapbro Pharma?
In 2022, Kapbro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lifemate India Private LimitedActive 23 years 3 monthsPrem Kapoor, Manish Kapoor and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Aug 2023 | ₹3.43 M | Open |
Others Creation Date: 10 Dec 2018 | ₹4.74 Cr | Open |
Yes Bank Limited Creation Date: 16 Jun 2016 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Kapbro Pharma?
Kapbro Pharma has a workforce of 26 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kapbro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kapbro Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
